FINWIRES · TerminalLIVE
FINWIRES

SGX:42C

6 stories mentioning SGX:42CUpdated just now

Every FINWIRES story that references SGX:42C, newest first.

Asia

IX Biopharma to Relocate Manufacturing Equipment to US; Shares Fall 8%

IX Biopharma (SGX:42C) will relocate its manufacturing equipment from its facility in Australia to a 503B-licensed plant in Nevada, U.S., according to a Monday filing with the Singapore Exchange.Shares of the healthcare services company were down over 8% in Tuesday's late-morning trading.The plant is managed by the company's joint venture partner, Orion Specialty Labs, and the relocation is expected to be completed in the third quarter of the year.The move also comes after the company secured a $41 million US Department of Defense contract.The relocation comes in the wake of the US unveiling tariffs of up to 100% on pharmaceutical imports from Australia.

SGX:42C
Asia

iX Biopharma Secures Listing and Quotation Notice for New Shares; Shares Zoom 11%

iX Biopharma (SGX:42C) received a listing and quotation notice from the Singapore Exchange Securities Trading for 1.3 million shares, according to a Thursday filing with the Singapore Exchange.Shares of the pharmaceutical and nutraceutical company surged nearly 11% in Monday trading.The notice is subject to shareholder approval and compliance with the bourse's listing requirements, the filing added.

SGX:42C
Asia

iX Biopharma Allots, Issues Nearly 1.2 Million Shares

iX Biopharma (SGX:42C) allotted and issued nearly 1.2 million shares at SG$0.06 per share, pursuant to the exercise of warrants, according to a Thursday filing with the Singapore Exchange.Following the issue, the company's share capital increased to close to 1.05 billion shares, with the new shares expected to be listed and quoted on or around April 27.

SGX:42C
Asia

iX Biopharma Allots, Issues Over 1.2 Million Shares

iX Biopharma (SGX:42C) allotted and issued 1.2 million shares at SG$0.06 per share, pursuant to the exercise of warrants, according to a Wednesday filing with the Singapore Exchange.Following the issue, the company's share capital increased to 1.05 billion shares, with the new shares expected to be listed and quoted on April 21.

SGX:42C
Asia

iX Biopharma to Issue Over 1 Million Shares to Anson Properties; Shares Down 3%

IX Biopharma (SGX:42C) signed a subscription agreement with Anson Properties to raise SG$440,537 through the issuance of 1,045,164 new shares at SG$0.4215 per share, according to a Thursday filing with the Singapore Exchange.Shares of the pharmaceutical company were down over 3% in Friday trading.Proceeds raised from the subscription will be used for general working capital needs.The company also proposed to issue 304,270 shares at SG$0.4215 per share to certain directors, in connection with the directors' fees for the period from Oct. 1 2025, till March 31, 2026.

SGX:42C
Asia

Taka Jewelry Names Group Financial Controller

Taka Jewelry (SGX:42L) named Cheah Lai Min as its group financial controller, effective May 4, according to a Monday filing with the Singapore Exchange.Min previously served as a finance manager at iX Biopharma (SGX:42C), the filing showed.

SGX:42CSGX:42L

Track with the FINWIRES app suite

FolioX
FolioX
Track SGX:42C in your portfolio
WheelAI
WheelAI
Analyze SGX:42C options with the wheel strategy
StockInsider
StockInsider
See market sentiment on SGX:42C